MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neurad.2023.10.007

Медицинская библиотека · Journal of neuroradiology = Journal de neuroradiologie · 2023

Safety and effectiveness of the LVIS and LVIS Jr devices for the treatment of intracranial aneurysms: Final results of the LEPI multicenter cohort study.

Forestier Géraud, Piotin Michel, Chau Yves, Derelle Anne-Laure, Brunel Hervé, Aggour Mohammed, Saleme Suzana, Levrier Olivier, Pierot Laurent, Barreau Xavier, Boubagra Kamel, Janot Kévin, Barbier Charlotte, Clarençon Frédéric, Chabert Emmanuel, Spelle Laurent, Arteaga Charles, Consoli Arturo, Machi Paolo, Blanc Raphaël, Rodesch Georges, Cortese Jonathan, Sourour Nader, Herbreteau Denis, Heck Olivier, Soize Sébastien, Marnat Gaultier, Rouchaud Aymeric, Anxionnat René, Sedat Jacques, Mounayer Charbel, LEPI investigators

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The Low profile visualized intraluminal support (LVIS)/LVIS Jr is a self-expanding braiding stent for the treatment of intracranial aneurysm. This study is to determine the safety and effectiveness of the LVIS/LVIS Jr for the treatment of intracranial aneurysms in a real-world setting.

METHODS

This prospective, observational, multicenter study enrolled patients with unruptured, ruptured and recanalized intracranial aneurysms treated with the LVIS stents, between February 2018 to December 2019. Primary endpoint was the cumulative morbidity and mortality rate (CMMR) assessed at 12 months follow-up (FU).

RESULTS

A total of 130 patients were included (62.3 % women, mean age 55.9 ± 11.4) on an intention-to-treat basis. Four patients (3.1 %) had 2 target aneurysms; 134 total aneurysms were treated. The aneurysms were mainly located on the middle cerebral artery (41/134; 30.6 %) and the anterior communicating artery (31/134; 23.1 %). The CMMR at 1 year linked to the procedure and/or device was 4.6 % (6/130). The overall mortality was 1.5 % (2/130), none of these deaths adjudged as being linked to the procedure and/or device. All aneurysms (134/134, 100 %) were successfully treated with LVIS stent and/or other devices. At a mean FU of 16.8 months post-procedure, complete/nearly complete occlusion was achieved in 112 aneurysms (92.6 %), and only 3 patients (2.5 %) required aneurysm retreatment.

CONCLUSION

This study provides evidence that the LVIS/LVIS Jr devices are safe and effective in the treatment of complex intracranial aneurysms, with very high rates of adequate occlusion at FU. These angiographic results are stable over time with an acceptable complication rate.

TRIAL REGISTRATION: ClinicalTrial.gov under NCT03553771.

Для цитирования: Forestier Géraud, Piotin Michel, Chau Yves, Derelle Anne-Laure, Brunel Hervé, Aggour Mohammed, Saleme Suzana, Levrier Olivier, Pierot Laurent, Barreau Xavier, Boubagra Kamel, Janot Kévin, Barbier Charlotte, Clarençon Frédéric, Chabert Emmanuel, Spelle Laurent, Arteaga Charles, Consoli Arturo, Machi Paolo, Blanc Raphaël, Rodesch Georges, Cortese Jonathan, Sourour Nader, Herbreteau Denis, Heck Olivier, Soize Sébastien, Marnat Gaultier, Rouchaud Aymeric, Anxionnat René, Sedat Jacques, Mounayer Charbel, LEPI investigators. Safety and effectiveness of the LVIS and LVIS Jr devices for the treatment of intracranial aneurysms: Final results of the LEPI multicenter cohort study.. Journal of neuroradiology = Journal de neuroradiologie. 2023. DOI: 10.1016/j.neurad.2023.10.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.